• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声造影与 CT 或 MRI 对比用于肝恶性肿瘤经皮射频消融治疗疗效的控制。

Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.

机构信息

Department of Medicine I, NOZ, Erlangen, Germany.

出版信息

Ultraschall Med. 2011 Apr;32(2):148-53. doi: 10.1055/s-0029-1245934. Epub 2011 Jan 11.

DOI:10.1055/s-0029-1245934
PMID:21225567
Abstract

PURPOSE

The goal of this study was to assess the informative value of contrast-enhanced ultrasound after radiofrequency ablation (RFA). Patients who had undergone RFA of malignant liver tumors were followed up with contrast-enhanced sonography (CEUS), computed tomography (CT) and/or magnetic resonance tomography (MRI), and the outcomes were compared.

MATERIALS AND METHODS

76 patients undergoing 194 RFAs for 118 hepatic neoplasms (n = 55 HCC, n = 63 metastases) in the course of a 7-year period were examined post-interventionally using CEUS and CT or MRI. During follow-up (gold standard of evaluation), contrast agent rim accumulations with a diameter greater than 5 mm and a growth rate of at least 25 % were counted as a recurrence.

RESULTS

CEUS-CT comparison group: A total of 65 scan pairs were compared. In 54 cases (83.1 %) the findings were the same with either method. In 7 cases (10.8 %) CEUS confirmed the correct diagnosis, and in 2 cases (3.1 %) only CT was correct. In 2 cases (3.1 %) both methods yielded incorrect results. Diagnostic accuracy (DA): CEUS 93.8 %, CT 86.2 %. CEUS-MRI comparison group: In 23 cases (88.5 %) of a total of 26 scan pairs, the findings were the same for both CEUS and MRI. In 3 discordant cases only CEUS confirmed the correct diagnosis (3 cases, 11.5 %). Diagnostic accuracy DA (n = 26): CEUS 100 %, MRI 88.4 %.

CONCLUSION

CEUS performs equally to CT and MRI in the follow-up of patients treated for liver tumors by RFA.

摘要

目的

本研究旨在评估射频消融(RFA)后超声造影(CEUS)的信息价值。对接受 RFA 治疗的恶性肝肿瘤患者进行 CEUS、计算机断层扫描(CT)和/或磁共振成像(MRI)随访,并对结果进行比较。

材料与方法

7 年间对 76 例 118 个肝脏肿瘤患者(55 例 HCC,63 例转移瘤)行 194 次 RFA,术后均行 CEUS 及 CT 或 MRI 检查。在随访期间(评估的金标准),以直径大于 5mm 且生长速度至少 25%为标准,计算对比剂边缘积聚的复发例数。

结果

CEUS-CT 比较组:共比较了 65 对扫描结果。两种方法的结果相同者 54 例(83.1%),CEUS 证实正确诊断 7 例(10.8%),CT 正确 2 例(3.1%),两种方法均不正确 2 例(3.1%)。诊断准确性(DA):CEUS 93.8%,CT 86.2%。CEUS-MRI 比较组:共 26 对扫描中,23 对(88.5%)结果相同,3 对(11.5%)仅 CEUS 结果正确。DA(n=26):CEUS 100%,MRI 88.4%。

结论

CEUS 在 RFA 治疗肝肿瘤患者的随访中与 CT 和 MRI 同样有效。

相似文献

1
Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.超声造影与 CT 或 MRI 对比用于肝恶性肿瘤经皮射频消融治疗疗效的控制。
Ultraschall Med. 2011 Apr;32(2):148-53. doi: 10.1055/s-0029-1245934. Epub 2011 Jan 11.
2
Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.单次经皮射频消融术后肝细胞癌局部复发的危险因素
J Gastroenterol. 2003;38(10):977-81. doi: 10.1007/s00535-003-1181-0.
3
Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.动态对比增强超声(DCE-US)与动态对比增强计算机断层扫描(DCE-CT)相比,用于简便快速评估肝细胞癌——一项初步研究。
Ultraschall Med. 2012 Dec;33(6):587-92. doi: 10.1055/s-0032-1325545. Epub 2012 Nov 15.
4
Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.超声造影引导下微波消融治疗肝脏转移瘤:39 例患者 125 个转移灶的经验
Ultraschall Med. 2011 Oct;32(5):492-6. doi: 10.1055/s-0029-1246002. Epub 2011 Jan 21.
5
Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.射频消融治疗肝细胞癌:困难病例的辅助技术。
Oncology. 2010 Jul;78 Suppl 1:94-101. doi: 10.1159/000315236. Epub 2010 Jul 8.
6
Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.经皮射频消融治疗小肝结直肠转移瘤:最长 10 年随访的局部反应率和长期生存率。
Radiology. 2012 Dec;265(3):958-68. doi: 10.1148/radiol.12111851. Epub 2012 Oct 22.
7
Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.超声造影(CEUS)用于肝脏局灶性病变的特征性诊断——临床实践中的前瞻性比较:CEUS与CT(德国超声医学与工程学会多中心试验)。本手稿的部分内容曾在2008年于达沃斯举行的三国超声会议上展示。
Ultraschall Med. 2009 Aug;30(4):383-9. doi: 10.1055/s-0028-1109673. Epub 2009 Aug 17.
8
Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.检测结直肠癌肝转移:灰阶超声与 SonoVue®低机械指数实时增强超声对比多层螺旋 CT 或 Gd-BOPTA-MRI 的前瞻性评估。
Ultraschall Med. 2010 Oct;31(5):500-5. doi: 10.1055/s-0028-1109751. Epub 2010 Apr 20.
9
Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.应用融合影像技术,结合增强超声造影与全氟丁烷基超声造影剂和增强 CT 用于评估经皮射频消融治疗富血管性肝细胞癌。
Eur J Radiol. 2012 Oct;81(10):2746-53. doi: 10.1016/j.ejrad.2011.11.052. Epub 2011 Dec 23.
10
Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases.冷循环微波刀治疗肝癌160例分析
Minim Invasive Ther Allied Technol. 2008;17(5):303-7. doi: 10.1080/13645700802383926.

引用本文的文献

1
Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review.小肾肿瘤的消融治疗及复发管理:综述
Life (Basel). 2024 Mar 28;14(4):450. doi: 10.3390/life14040450.
2
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy.接受联合免疫治疗联合局部区域治疗后达到临床完全缓解的肝细胞癌患者的停药标准
Liver Cancer. 2023 Jul 28;12(4):289-296. doi: 10.1159/000532023. eCollection 2023 Sep.
3
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.
阿替利珠单抗联合贝伐单抗加或不加根治性转化治疗经动脉化疗栓塞不适合的中期肝细胞癌患者实现完全缓解和无药状态:一项多中心概念验证研究
Liver Cancer. 2023 Feb 7;12(4):321-338. doi: 10.1159/000529574. eCollection 2023 Sep.
4
Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy.非手术复发性肝细胞癌的放射学表现:从局部区域治疗到免疫治疗。
World J Gastroenterol. 2023 Mar 21;29(11):1669-1684. doi: 10.3748/wjg.v29.i11.1669.
5
Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study.CT/MRI肝脏影像报告和数据系统(LI-RADS)治疗反应算法在对比增强超声中的应用:一项可行性研究
J Hepatocell Carcinoma. 2022 May 20;9:437-451. doi: 10.2147/JHC.S353914. eCollection 2022.
6
Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.结节硬度的变化可能预测局部消融治疗的反应:一系列肝细胞癌患者
PLoS One. 2018 Feb 14;13(2):e0192897. doi: 10.1371/journal.pone.0192897. eCollection 2018.
7
International guidelines for contrast-enhanced ultrasonography: ultrasound imaging in the new millennium.国际对比增强超声造影指南:新世纪的超声成像
Ultrasonography. 2016 Apr;35(2):89-103. doi: 10.14366/usg.15057. Epub 2015 Dec 23.
8
Contrast-enhanced ultrasonography: advance and current status in abdominal imaging.超声造影:腹部影像学的进展与现状。
Ultrasonography. 2015 Jan;34(1):3-18. doi: 10.14366/usg.14034. Epub 2014 Sep 12.
9
Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.肝细胞癌的管理:超声造影的作用
World J Radiol. 2014 Jan 28;6(1):7-14. doi: 10.4329/wjr.v6.i1.7.
10
Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma.超声造影在评价超声引导经皮微波消融治疗肾癌疗效中的作用。
Radiol Oncol. 2013 Oct 8;47(4):398-404. doi: 10.2478/raon-2013-0038. eCollection 2013.